Generalized Myasthenia Gravis : Classification, Clinical Presentation, Natural History, and Epidemiology - 13/04/18
, Nicholas J. Silvestri, MD bRésumé |
Myasthenia gravis (MG) is a rare disease, but the most common disorder of the neuromuscular junction. It is the prototypic autoimmune disease most commonly caused by antibodies to the acetylcholine receptor (AChR) leading to characteristic fatigable weakness of the ocular, bulbar, respiratory, axial, and limb muscles. The majority of patients with MG first present with ocular symptoms. Most patients with MG will experience at least 1 exacerbation of symptoms throughout the course of their illness. This article will cover the epidemiology, clinical presentation, classification, and natural history of MG.
Le texte complet de cet article est disponible en PDF.Keywords : Myasthenia gravis, Acetylcholine receptor, Antimuscle-specific kinase, Occular
Plan
Vol 36 - N° 2
P. 253-260 - mai 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
